Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_268be9afa00cf55b5aa72b1612151ecb |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K5-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B1-041 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K3-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08L33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-301 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F212-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F212-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K5-523 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K5-521 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-1807 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08K5-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08F220-40 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F212-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F212-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K5-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08F220-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K3-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08K5-523 |
filingDate |
2019-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e64fd8ea3351221330e473765bc73c30 |
publicationDate |
2019-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2019233563-A1 |
titleOfInvention |
Curable composition, cured product, optical member, lens, and method for producing cured product |
abstract |
A curable composition contains: a cardo skeleton-containing monomer having two or more (meth)acryloyl groups in a molecule; an aromatic ring-containing monofunctional (meth)acrylate monomer; and an acidic phosphate ester, in which the acidic phosphate ester is a compound represented by General Formula (1), and the content of the acidic phosphate ester is 0.003% to 1% by mass with respect to a total mass of the curable composition. |
priorityDate |
2016-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |